Mr. Makoto Yamada | Cytology | Best Researcher Award

Mr. Makoto Yamada | Seirei Hamamatsu General Hospital | Japan 

Mr. Makoto Yamada is a distinguished cytopathology specialist with a long and dedicated career in clinical laboratory sciences. He began his professional journey at Seirei Numazu General Hospital, where he worked in the Department of Clinical Laboratory, before continuing his service at Seirei Hamamatsu General Hospital, where he has contributed. An alumnus of Tohoku University’s Medical Technology Junior College, he developed strong expertise in diagnostic pathology with a special focus on breast tumors. His research includes groundbreaking work on solid papillary carcinoma of the breast, with two major publications recognized internationally. One of his studies was cited in the World Health Organization’s Classification of Tumours, highlighting the global impact of his contributions. His recent work further explores the cytological relationship between solid papillary carcinoma and neuroendocrine tumors, advancing knowledge in diagnostic cytopathology. With decades of service and influential research, Makoto Yamada has made lasting contributions to medical science.

Publication Profile

Scopus

Academic and Professional Background

Mr. Makoto Yamada has established a distinguished academic and professional career in cytopathology, with a particular focus on breast tumor research. His work has contributed significantly to the understanding of solid papillary carcinoma of the breast, where his research has provided valuable cytological insights that have influenced international medical classifications. One of his notable studies examined the cytological features of solid papillary carcinoma and was later cited in the World Health Organization’s Classification of Tumours, underscoring the global recognition of his contributions. Building on this foundation, his more recent study expanded the scope by analyzing a larger number of cases and conducting a systematic review that highlighted the cytological similarities between solid papillary carcinoma and neuroendocrine tumors of the breast. These findings have advanced diagnostic knowledge and supported the refinement of pathological practices. Through his dedicated research, Makoto Yamada continues to play a vital role in improving diagnostic cytopathology and clinical outcomes.

Professional Experience

Mr. Makoto Yamada has built a remarkable professional journey in the field of clinical laboratory sciences, marked by dedication and consistency. He began his career at Seirei Numazu General Hospital in Numazu, where he served in the Department of Clinical Laboratory and gained valuable practical experience in diagnostic and clinical work. His early years provided a strong foundation for his future contributions to cytopathology and laboratory medicine. Following this, he joined Seirei Hamamatsu General Hospital in Hamamatsu, where he has continued his service in the Department of Clinical Laboratory. His long-standing role at this institution reflects his commitment to advancing diagnostic practices and improving patient care through accurate laboratory results and innovative approaches in cytology. Over the decades, Makoto Yamada has established himself as a trusted professional whose expertise and dedication have supported both clinical excellence and impactful research in pathology, particularly in the study of breast tumor cytology.

Research Focus

Mr. Makoto Yamada research focus lies primarily in the field of diagnostic cytopathology with an emphasis on rare and complex tumor types. His studies have explored breast tumor pathology, particularly solid papillary carcinoma, where his findings have been influential enough to be cited by the World Health Organization in its classification of breast tumors. Recently, his work has extended into the area of intrathyroidal thymic carcinoma, reflecting his interest in advancing preoperative cytological diagnosis for uncommon and diagnostically challenging cancers. By investigating the cytological features of both common and rare tumor entities, he contributes to improving the accuracy of early diagnosis, guiding treatment decisions, and refining pathological classifications. His research highlights the importance of detailed cytological evaluation in bridging gaps between clinical findings and histopathological confirmation. Through his consistent efforts, Makoto Yamada strengthens the role of cytopathology as a vital tool in modern diagnostic medicine, particularly in oncology and rare tumor identification.

Publication Top Notes